Kezar Life Sciences, Inc. (KZR)
NASDAQ·Healthcare·Biotechnology
$7.34
+0.69%
Mkt Cap $51.26M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$6.00
Range $5.00 – $7.00
Implied Upside
-18.3%
Consensus $6.00 vs current $7.34
NASDAQ·Healthcare·Biotechnology
$7.34
+0.69%
Mkt Cap $51.26M
No recent rating data.
Price Target (5 analysts)
$6.00
Range $5.00 – $7.00
-18.3%
Consensus $6.00 vs current $7.34